NEURACAP
Sector OutlookPublished · 21 pages · Free to read

Test, Measurement and Inspection Equipment Sector Outlook — September 2026

This sector outlook covers Test, Measurement and Inspection Equipment as of September 2026, comparing general-purpose instruments against higher-rated adjacent models across valuation, margin and precedent-transaction evidence.

For information only. Not an appraisal or a fairness opinion.

What moved since: Test, Measurement and Inspection Equipment M&A update, 14–28 September 2026

Key figures

Sector median valuation
17.2x
EV/EBITDA (CY2027E)
Adjacent-model median
19.5x
EV/EBITDA (CY2027E)
General-purpose median
14.1x
EV/EBITDA (CY2027E)
Premium-tier median
22.2x
EV/EBITDA (CY2027E)

Read the report

NeuraCap

INDUSTRIALS › CAPITAL GOODS › TEST, MEASUREMENT AND INSPECTION EQUIPMENT

Test, Measurement and Inspection: Value Splits by Model

The report shows how business model, margin and earnings durability distinguish valuation across the peer set.

September 2026 · Prepared by NeuraCap AI · Confidential

Market data as of 2026-09-28 · primary valuation basis EV / EBITDA (CY2027E)

Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice

1

1 / 21

Executive summary

Test, Measurement and Inspection Equipment splits into two valuation tiers: adjacent models trade at 19.5x against 14.1x for general-purpose instruments, and the premium end holds 22.2x versus 10.1x at the discount end. Margin, not forecast growth, tracks with the higher rating — names above the 24% margin line carry 20.9x against 11.8x below it. The evidence points toward revenue mix, pricing and retention as the operating priorities for the next twelve months.

Key findings

  • Adjacent models command higher valuations than general-purpose instruments.
  • Forward pricing shows a wide gap between the premium and discount tiers.
  • Faster forecast growth pairs with the lower rating in this peer set.
  • Higher margins sit alongside the higher-rated segment.

What each page shows

The analyst’s walkthrough of the deck, page by page.

  1. 01

    INDUSTRIALS › CAPITAL GOODS › TEST, MEASUREMENT AND INSPECTION EQUIPMENT

    Cover slide introducing the Test, Measurement and Inspection Equipment sector outlook dated September 2026.

    We open with the sector's core finding: valuation splits by business model, not by size. The pages that follow show where that split comes from and what it means for the path ahead.

    Everything on this page

    INDUSTRIALS › CAPITAL GOODS › TEST, MEASUREMENT AND INSPECTION EQUIPMENT Test, Measurement and Inspection: Value Splits by Model The report shows how business model, margin and earnings durability distinguish valuation across the peer set. September 2026 · Prepared by NeuraCap AI · Confidential Market data as of 2026-09-28 · primary valuation basis EV / EBITDA (CY2027E) Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 1

  2. 02
    CONTENTS

    What This Report Covers

    Contents slide listing the report's five sections and appendix.

    The report runs five sections plus an appendix, starting with the bottom line so the conclusion comes first. Each later section builds the evidence behind that opening view.

    Everything on this page

    CONTENTS What This Report Covers 01 The Bottom Line Business Model and Earnings Quality Divide the Sector 02 The Landscape One Sector Label Covers Two Different Earnings Models 03 Valuation & Situations The Premium End Retains a Clear Forward Valuation Gap 04 Precedent Transactions Strategic Fit and Platform Potential Shape Buyer Interest 05 Strategic Implications Strengthen the Earnings Mix Before Choosing the Next Move 06 Appendix Comparables Detail, Methodology, Sources and Assumptions Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 2

  3. 03
    01 · THE BOTTOM LINE

    Test, Measurement and Inspection Equipment Splits Between General-Purpose Instruments and Higher-Rated Adjacent Models

    Bottom-line slide summarizing that the sector splits between general-purpose instruments and higher-rated adjacent models.

    Adjacent models carry a median of 19.5x against 14.1x for general-purpose bench and handheld instruments, a valuation gap that recurs across every cut in this report. The premium end holds at 22.2x versus 10.1x at the discount end, even after forward earnings are already priced in. Faster forecast growth actually sits with the lower rating in this set, so growth alone does not explain the split. Margin does: names above the 24% margin line sit at 20.9x against 11.8x below it, which is where we focus the rest of the deck.

    Everything on this page

    01 · THE BOTTOM LINE Test, Measurement and Inspection Equipment Splits Between General-Purpose Instruments and Higher-Rated Adjacent Models The full story on one page · figures on EV / EBITDA (CY2027E), market data as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Primary valuation basis: EV / EBITDA on CY2027E consensus (6 of 8 companies eligible; multiples failing the platform's plausibility gates are excluded, never plotted). Qualitative characterisations are NeuraCap views. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 3 1 Adjacent Models Sit Above General-Purpose Instruments Adjacent models sit at 19.5x in the middle of their range, alongside 14.1x for general-purpose bench and handheld test instruments. The higher-rated group includes businesses positioned around specialist measurement, communications testing and screening programme services. 2 Forward Pricing Leaves a Wide Gap Between the Two Ends The premium end sits at 22.2x, against 10.1x at the discount end. A forward EV / EBITDA multiple already credits forecast earnings, so the remaining gap signals a market judgment about their durability. 3 Higher Forecast Growth Sits with the Lower Rating Among the six names with a forward EV / EBITDA estimate, the three above the 7% growth split sit at 16.3x, while the other three sit at 20.9x. Forecast growth alone does not organise valuation in this set. 4 Higher Margins Sit on the Higher-Rated Side Three names sit above both the valuation midpoint and the 24% margin midpoint, while three sit below both. Installed-base aftermarket, calibration and repair, and method qualification are the operating qualities that can support durable margins. 17.2x Sector median EV/EBITDA CY2027E consensus · 6 rated of 8 companies 22.2x Premium end EV/EBITDA vs 10.1x at the discount end top quartile (n=2) against bottom quartile (n=2) on EV/EBITDA — the spread the report explains 14 Transactions with disclosed terms 40 recorded in this tier · 3 told as case studies, the full list in the appendix

  4. 04
    SECTION 02

    02

    Section divider introducing the market-map and landscape pages on business-model differences.

    One sector label covers two different earnings models, and the next pages separate them by segment and by rating.

    Everything on this page

    SECTION 02 02 THE LANDSCAPE One Sector Label Covers Two Different Earnings Models General-purpose instruments and adjacent models bring different revenue quality, operating risk and valuation. 02 of 06 Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 4

  5. 05
    02 · MARKET MAP

    Adjacent Models Carry the Higher Rating Across an Evenly Split Market

    Market-map slide grouping eight approved companies by segment and showing each group's median valuation.

    Across an evenly split market, adjacent models hold the higher median rating at 19.5x, while general-purpose instruments sit at 14.1x. That gap shows up consistently once companies are grouped by what they actually sell, not just by sector label. For a reader assessing where to lean into investment, the segment view is the more useful cut than the sector average.

    Everything on this page

    02 · MARKET MAP Adjacent Models Carry the Higher Rating Across an Evenly Split Market 8 approved companies grouped by business segment · median EV / EBITDA (CY2027E) per group · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Segment grouping follows the platform's classification; group medians on rated names only. "Why it matters" lines are NeuraCap views. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 5 GENERAL-PURPOSE BENCH AND HANDHELD TEST INSTRUMENTS 4 cos median 14.1x Keysight (KEYS) Ralliant (RAL) OSI Systems (OSIS) MIND Technology (MIND) This group represents 50% of the approved companies and sits at 14.1x in the middle of its rated range, with differentiation resting on installed base, aftermarket attach and product position. ADJACENT MODELS 4 cos median 19.5x AMETEK (AME) Mettler-Toledo (MTD) Viavi Solutions (VIAV) Mistras Group (MG) This group represents 50% of the approved companies and sits at 19.5x in the middle of its range, spanning specialist measurement, communications testing and screening programme services.

  6. 06
    02 · LANDSCAPE

    Different Revenue Models Sit Behind the Sector Label

    Landscape slide describing what each segment does and why the difference matters.

    Different revenue models sit behind the single sector label, and each carries its own mix of recurring and short-cycle demand. Segment context here explains why the valuation gap between adjacent models and general-purpose instruments persists across the peer set. The full company-level detail sits in the appendix for anyone tracing a specific name.

    Everything on this page

    02 · LANDSCAPE Different Revenue Models Sit Behind the Sector Label Segment view of the approved universe · EV / EBITDA (CY2027E) medians on rated names · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. "What they do / why it matters" is a NeuraCap view. Full company-level detail in the appendix and companion tables. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 6 Segment n Share of universe Median EV/EBITDA Names to know What they do — and why it matters General-purpose bench and handheld test instruments 4 50% 14.1x Keysight Technologies, Inc. (KEYS) · Ralliant Corp (RAL) · +2 more Installed base shapes resilience. Instrument economics depend on design wins, method qualification and the calibration, repair and spares pulled through after placement. Commoditised hardware and thin aftermarket attach can weaken that profile. Adjacent models 4 50% 19.5x AMETEK, Inc. (AME) · Mettler-Toledo International Inc. (MTD) · +2 more Specialisation broadens the model. The group spans electrical and analytical measurement, communications test systems and screening programme services. Its value case rests on proprietary technology, qualified applications, service content or programme durability.

  7. 07
    SECTION 03

    03

    Section divider introducing the public-market valuation and situation-mapping pages.

    The premium end retains a clear forward valuation gap over the discount end, and that gap already credits forecast earnings — so the pages ahead test what is really being paid for.

    Everything on this page

    SECTION 03 03 VALUATION & SITUATIONS The Premium End Retains a Clear Forward Valuation Gap That gap already credits forecast earnings and therefore puts durability under scrutiny. 03 of 06 Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 7

  8. 08
    03 · PUBLIC MARKET VALUATION

    Forward Pricing Separates the Premium End from the Discount End

    Valuation slide ranking all six rated companies by EV/EBITDA (CY2027E) against the 17.2x sector median.

    Sorting the rated set from richest to cheapest shows a sector median of 17.2x, with the premium tier at 22.2x and the discount tier at 10.1x. That spread is wide enough that it separates two distinct valuation tiers rather than reflecting noise around a single multiple. For a reader weighing where a name sits today, tier position is the more informative signal than the sector average alone.

    Everything on this page

    03 · PUBLIC MARKET VALUATION Forward Pricing Separates the Premium End from the Discount End EV / EBITDA (CY2027E) · all 6 rated companies, sorted descending · sector median 17.2x · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Primary valuation basis: EV / EBITDA on CY2027E consensus (6 of 8 companies eligible; multiples failing the platform's plausibility gates are excluded, never plotted). Tier zones are NeuraCap groupings cut at the rated set's quartiles; every multiple quoted on this page is a median on the same EV / EBITDA (CY2027E) basis. Panel commentary is a NeuraCap view. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 8 PREMIUM · median 22.2x CORE · median 17.2x DISCOUNT · median 10.1x Sector median 17.2x WHAT SEPARATES THE TWO ENDS The forward gap remains wide. The premium end sits at 22.2x, while the discount end sits at 10.1x. As these are forward EV / EBITDA ratings, the comparison already incorporates forecast earnings. Specialisation sits near the top. AMETEK, Inc. [AME] and Mettler-Toledo International Inc. [MTD] occupy specialist electrical, power, laboratory and analytical measurement positions at the premium end. Revenue quality still matters. The commercial test is whether installed-base service, calibration and repair, consumables or qualified methods can support earnings through short-cycle and programme volatility.

  9. 09
    03 · VALUATION DRIVERS

    Profitability Separates the Two Ends: Names Above the 24% Margin Line Carry 20.9x Against 11.8x Below It

    Valuation-drivers slide splitting the rated set by revenue growth and by EBITDA margin.

    Margin organizes valuation more cleanly than growth in this set: names above the 24% margin line carry 20.9x against 11.8x below it. Growth actually runs the other way — names above the 7% growth split sit at 16.3x, lower than the 20.9x carried by the higher-margin cohort. That pattern is an association we observe in the data, not a claim that margin causes the rating. It points a reader toward margin durability as the more useful diligence question.

    Everything on this page

    03 · VALUATION DRIVERS Profitability Separates the Two Ends: Names Above the 24% Margin Line Carry 20.9x Against 11.8x Below It Median EV / EBITDA (CY2027E) by revenue-growth cohort and by EBITDA-margin cohort (each split at its covered median) · rated names with estimates · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Cohort medians on rated names with the required estimates (faster n=3; slower n=3; higher-margin n=3; lower-margin n=3). Driver readings are NeuraCap views on the supplied data — association, not causation. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 9 EV/EBITDA, median per cohort · growth split at 7% · EBITDA-margin split at 24% The Growth Split Runs Against a Simple Premium Story Among the six names with a forward EV / EBITDA estimate, the three above the 7% growth split sit at 16.3x, versus 20.9x for the other three. This is an observed association, not evidence that growth lowers valuation. Aftermarket Can Steady the Earnings Base Calibration and repair, spares and consumables can reduce dependence on book-and-ship instruments or milestone-driven systems work. The relevant operating test is attach, renewal and installed-base activity. Qualification Can Protect Customer Position Method qualification, accreditation and approved-vendor status can deepen switching costs. Their value depends on whether they translate into repeat orders, service activity and durable margin.

  10. 10
    03 · SITUATION MAP

    Valuation and Margin Move Together Across the Rated Names

    Situation-map slide cutting the rated names by valuation versus the 17.2x median and by margin versus the 24% median.

    Plotting valuation against margin shows the two moving together across the rated names, reinforcing the pattern from the prior page. This is an observation about where each name sits today, not a recommendation to act on any single name. It gives a reader a quick map of which quadrant a given company falls into before going deeper.

    Everything on this page

    03 · SITUATION MAP Valuation and Margin Move Together Across the Rated Names Cut on EV / EBITDA vs the sector median (17.2x) (rows) and EBITDA margin vs the covered median (24%) (columns) · observations, not recommendations Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Situation boundaries are the cohort's own medians (Directional, NeuraCap view). This page characterises situations; it does not recommend buying or selling any security. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 10 Higher Multiple, Higher Margin Above-median multiple · above-median EBITDA margin 3 names AMETEK, Inc. (AME) · Mettler-Toledo International Inc. (MTD) · Viavi Solutions Inc. (VIAV) AMETEK, Inc. [AME], Mettler-Toledo International Inc. [MTD] and Viavi Solutions Inc. [VIAV] sit above both the 17.2x valuation midpoint and the 24% margin midpoint. Their position puts margin durability and earnings quality at the centre of the value discussion. Higher Multiple, Lower Margin Above-median multiple · below-median EBITDA margin 0 names No rated names sit in this cell as of the analysis date. Lower Multiple, Higher Margin Below-median multiple · above-median EBITDA margin 0 names No rated names sit in this cell as of the analysis date. Lower Multiple, Lower Margin Below-median multiple · below-median EBITDA margin 3 names Ralliant Corp (RAL) · OSI Systems, Inc. (OSIS) · Mistras Group, Inc. (MG) Ralliant Corp [RAL], OSI Systems, Inc. [OSIS] and Mistras Group, Inc. [MG] sit below both midpoints. The operating question is whether mix, pricing, aftermarket attach or utilisation can improve earnings durability.

  11. 11
    03 · THE AGENDA

    The Operating Paths Ahead Differ in the Earnings Quality They Can Build

    Agenda slide framing the open questions the operating paths ahead need to resolve.

    The paths ahead differ mainly in the earnings quality they can build, not in headline growth. We frame this as a set of questions an owner or acquirer should work through, rather than a fixed recommendation. It sets up the strategic-implications section that follows.

    Everything on this page

    03 · THE AGENDA The Operating Paths Ahead Differ in the Earnings Quality They Can Build NeuraCap view · framed as the questions an owner or acquirer should resolve · observations, not recommendations Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. All content on this page is Directional — NeuraCap advisory judgment grounded in the cohort data shown earlier. It does not constitute investment advice. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 11 Deepen Installed-Base Economics Prioritise calibration and repair, spares, consumables and service renewals where the installed base can support repeat activity and steadier earnings. What changes the answer: Attach, renewal and active-unit trends show that recurring activity can outgrow short-cycle instrument demand. Focus the Portfolio Around Qualified Niches Concentrate investment where proprietary measurement, method qualification, accreditation or approved-vendor status support customer retention and margin. What changes the answer: Product and customer analysis shows durable repeat demand around qualified applications. Build or Buy the Missing Capability Compare internal investment with acquisitions in sensing, software, calibration and repair, or service density. The choice should reflect integration capacity and the quality of the resulting revenue mix. What changes the answer: The capability gap is clear, customer pull is visible and the economics exceed the internal development case.

  12. 12
    SECTION 04

    04

    Section divider introducing the precedent-transaction case studies.

    Strategic fit and platform potential shape buyer interest, and the transaction record spans several different routes to that fit.

    Everything on this page

    SECTION 04 04 PRECEDENT TRANSACTIONS Strategic Fit and Platform Potential Shape Buyer Interest The transaction record spans scaled strategic combinations, specialist additions and sponsor-backed platforms. 04 of 06 Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 12

  13. 13
    04 · DEAL CASE STUDIES

    Precedent Transactions Show Several Routes to Strategic Fit

    Deal case-studies slide walking through three of fourteen disclosed-terms transactions as illustrative precedents.

    We walk through three of the fourteen disclosed-terms transactions as case studies, chosen to show different routes to strategic fit rather than a single template. Deal multiples here are LTM at announcement, so they sit on a different basis from the CY2027E public multiples used elsewhere and are not compared directly. The complete transaction list, including names without disclosed terms, sits in the appendix for a fuller read.

    Everything on this page

    04 · DEAL CASE STUDIES Precedent Transactions Show Several Routes to Strategic Fit 3 of 14 transactions with disclosed terms, told as case studies · multiples on LTM financials at announcement where disclosed · the complete list is in the appendix · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. 57 precedent record(s) carry data-quality flags (deal value unit unresolved; divestiture roles reassigned; duplicate precedent id); figures are shown as recorded in the filing. 26 recorded transactions with neither a disclosed value nor a multiple are omitted from the precedent list and the case studies (kept in the companion workbook). Deal multiples are LTM at announcement (Definitive, from filings); they are not directly comparable to the CY2027E public basis and no spread is claimed. "Why the deal happened" is a NeuraCap read of the recorded evidence. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 13 Apr-2023 $8.3B Emerson Electric Co. Emerson Electric Co. Put Scale Behind National Instruments Corp. EV / LTM revenue 4.9x EV / LTM EBITDA n/a WHY THE DEAL HAPPENED The transaction suggests Emerson Electric Co. viewed a scaled test and measurement platform as strategically relevant to its industrial portfolio. The size also indicates conviction in a broad platform rather than a narrow product addition. HOW THE TARGET WAS VALUED National Instruments Corp. was valued at $8.3B and 4.9x revenue. That provides a disclosed revenue benchmark for a scaled strategic combination. May-2026 $5.0B Bain Capital Bain Capital Backed NIRLAB SA as a Scaled Platform EV / LTM revenue 6.8x EV / LTM EBITDA n/a WHY THE DEAL HAPPENED The transaction suggests Bain Capital saw platform potential in NIRLAB SA. The disclosed size points to a substantial sponsor commitment within the sector. HOW THE TARGET WAS VALUED NIRLAB SA was valued at $5.0B and 6.8x revenue. That places the transaction toward the upper end of the disclosed revenue multiples in the record. May-2025 $920M AMETEK, Inc. AMETEK, Inc. [AME] Added FARO Technologies to Its Measurement Portfolio EV / LTM revenue 2.7x EV / LTM EBITDA n/a WHY THE DEAL HAPPENED The transaction suggests a strategic fit between AMETEK, Inc. [AME] and an adjacent measurement asset. The pairing is consistent with an industrial buyer extending its specialist instrumentation portfolio. HOW THE TARGET WAS VALUED FARO Technologies was valued at $920M and 2.7x revenue. The disclosed revenue multiple provides a reference point for a strategic measurement addition.

  14. 14
    SECTION 05

    05

    Section divider introducing the strategic-implications section.

    Strengthening the earnings mix is the work that precedes the next move, and the following page sets out the specific questions to resolve.

    Everything on this page

    SECTION 05 05 STRATEGIC IMPLICATIONS Strengthen the Earnings Mix Before Choosing the Next Move Installed-base revenue, margin durability and portfolio focus are the operating questions to resolve. 05 of 06 Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 14

  15. 15
    05 · STRATEGIC IMPLICATIONS

    The Valuation Split Points the Work Toward Revenue Mix, Pricing and Retention

    Strategic-implications slide translating the valuation split into questions on revenue mix, pricing and retention.

    The valuation split we've shown points toward three practical questions: how much of revenue is recurring, how pricing is set, and how well customers are retained. These are framed as questions for the next twelve months, not as recommendations to act immediately. Owners, management teams and boards each have a distinct angle on the same underlying evidence, which the next panels lay out.

    Everything on this page

    05 · STRATEGIC IMPLICATIONS The Valuation Split Points the Work Toward Revenue Mix, Pricing and Retention NeuraCap view · the questions this data puts on the table for the next twelve months Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. This page is Directional — NeuraCap views drawn from the analysis in this report. Observations, not recommendations. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 15 FOR OWNERS Protect the Durable Earnings Base Separate repeat installed-base activity from short-cycle orders and project work. Direct capital toward the products and services with stronger retention, aftermarket attach and margin durability. FOR MANAGEMENT Make Portfolio Choices Explicit Test which franchises benefit from method qualification, proprietary measurement or service density. Reallocate investment where those advantages translate into repeat demand and resilient economics. FOR BOARDS Set the Build-Versus-Buy Boundary Define which sensing, software, service or geographic capabilities belong inside the platform. Use customer pull, integration capacity and earnings quality to frame capital allocation.

  16. 16
    SECTION 06

    06

    Section divider introducing the appendix covering the full comparable universe, methodology and sources.

    The final section carries the full universe behind every figure in the body, the valuation basis used, and where each underlying disclosure can be found.

    Everything on this page

    SECTION 06 06 APPENDIX The Full Universe, Methodology and Sources Comparables detail behind every figure in the body, the valuation basis, and where each underlying disclosure lives. 06 of 06 Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 16

  17. 17
    06 · PUBLIC COMPARABLES (1 OF 1)

    Public Comparables on EV / EBITDA (CY2027E), Grouped by Valuation Tier

    Public-comparables appendix listing all eight companies, six rated and two without an eligible multiple, grouped by valuation tier.

    This page lists all six rated companies with an eligible EV/EBITDA (CY2027E) multiple, shaded against the 17.2x sector median, plus the two names without an eligible multiple. It is the full data set behind the valuation pages earlier in the report. A reader who wants to check any single name's position can start here.

    Everything on this page

    06 · PUBLIC COMPARABLES (1 OF 1) Public Comparables on EV / EBITDA (CY2027E), Grouped by Valuation Tier Teal shading marks a EV/EBITDA above the sector median (17.2x); amber marks below · 6 rated companies; 2 not rated (no eligible EV/EBITDA) · tickers link to the underlying source · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. All 6 rated rows are in this appendix and in the companion workbook, which carries the complete field set. Names without an eligible multiple are listed in the companion workbook. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 17 Company Ticker Segment EV EV/EBITDA (CY2027E) Rev growth EBITDA margin Rule of 40 PREMIUM — ≥20.2x · median 22.2x · 2 companies Mettler-Toledo International Inc. MTD Laboratory and analytical measurement instruments $33.4B 23.5x 5% 31% 37 AMETEK, Inc. AME Electrical and power measurement instrumentation $59.7B 20.9x 7% 32% 39 CORE — 12.9x–20.2x · median 17.2x · 2 companies Viavi Solutions Inc. VIAV Lab and production test systems for communications… $10.2B 18.2x 12% 27% 40 Ralliant Corp RAL General-purpose bench and handheld test instruments $8.8B 16.3x 7% 20% 29 DISCOUNT — <12.9x · median 10.1x · 2 companies OSI Systems, Inc. OSIS General-purpose bench and handheld test instruments $3.9B 11.8x 9% 16% 26 Mistras Group, Inc. MG Screening programme services and checkpoint operations $879M 8.5x 5% 13% 18

  18. 18
    06 · PRECEDENT TRANSACTIONS (1 OF 2)

    All Precedent Transactions with Disclosed Terms, Newest First

    Precedent-transactions appendix listing all fourteen disclosed-terms transactions out of forty recorded, newest first.

    This page lists the fourteen transactions with disclosed terms out of forty recorded, ordered newest first. Multiples shown are LTM at announcement and sit on a different basis from the CY2027E public multiples used elsewhere in the report. It is the reference list behind the case studies shown earlier.

    Everything on this page

    06 · PRECEDENT TRANSACTIONS (1 OF 2) All Precedent Transactions with Disclosed Terms, Newest First 14 transactions with disclosed terms in this tier (40 recorded) · multiples on LTM financials at announcement where disclosed · deal values link to the underlying filing · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. 57 precedent record(s) carry data-quality flags (deal value unit unresolved; divestiture roles reassigned; duplicate precedent id); figures are shown as recorded in the filing. 26 recorded transactions with neither a disclosed value nor a multiple are omitted from the precedent list and the case studies (kept in the companion workbook). Deal multiples are LTM at announcement (Definitive, from filings); they are not directly comparable to the CY2027E public basis and no spread is claimed. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 18 Date Transaction EV EV/LTM Rev EV/LTM EBITDA Why it matters May-2026 Bain Capital → NIRLAB SA $5.0B 6.8x n/a Bain Capital announced the acquisition of NIRLAB SA at $5.0B and 6.8x revenue. The transaction suggests sponsor interest where a measurement platform can support further development. May-2025 AMETEK, Inc. → FARO Technologies $920M 2.7x n/a AMETEK, Inc. [AME] announced the acquisition of FARO Technologies at $920M and 2.7x revenue. The pairing points to continued strategic interest in adjacent measurement capabilities. Jul-2024 Spectris plc → MICROMERITICS INSTRUMENT CORPORATION n/a 0.7x 8.8x Spectris plc announced the acquisition of MICROMERITICS INSTRUMENT CORPORATION at 0.7x revenue and 8.8x EBITDA. The disclosed measures provide both revenue and earnings reference points. Mar-2024 GTCR LLC → The L.S. Starrett Co. n/a n/a 6.9x GTCR LLC announced the acquisition of The L.S. Starrett Co. at 6.9x EBITDA. The transaction suggests financial interest can extend beyond service-led platforms. Apr-2023 Emerson Electric Co. → National Instruments Corp. $8.3B 4.9x n/a Emerson Electric Co. announced the acquisition of National Instruments Corp. at $8.3B and 4.9x revenue. The transaction points to the strategic relevance of scaled test and measurement platforms. Jul-2021 Viavi Solutions Inc. → EXFO Inc. n/a 1.3x 14.1x Viavi Solutions Inc. [VIAV] announced the acquisition of EXFO Inc. at 1.3x revenue and 14.1x EBITDA. The combination suggests strategic logic in expanding a focused communications testing position. May-2021 MKS Instruments, Inc. → Photon Control Inc. n/a n/a 16.5x MKS Instruments, Inc. announced the acquisition of Photon Control Inc. at 16.5x EBITDA. The disclosed multiple benchmarks a specialist addition on forward earnings. Apr-2021 Spectris plc (via subsidiary Hottinger Brüel & Kjær A/S) → Concurrent Real-Time, Inc n/a n/a 8.8x The transaction involving Spectris plc (via subsidiary Hottinger Brüel & Kjær A/S) and Concurrent Real-Time, Inc was terminated after being recorded at 8.8x EBITDA. Dec-2020 Amphenol Corporation → MTS Systems Corporation n/a n/a 14.2x Amphenol Corporation announced the acquisition of MTS Systems Corporation at 14.2x EBITDA. The pairing suggests a strategic route for adding adjacent measurement capabilities.

  19. 19
    06 · PRECEDENT TRANSACTIONS (2 OF 2)

    All Precedent Transactions with Disclosed Terms, Newest First

    Second page of the precedent-transactions appendix, continuing the same disclosed-terms list.

    This page continues the same list of fourteen disclosed-terms transactions, still ordered newest first. The same basis note applies: these are LTM multiples at announcement, not directly comparable to the CY2027E public basis used elsewhere. Together with the prior page, it completes the disclosed-terms record.

    Everything on this page

    06 · PRECEDENT TRANSACTIONS (2 OF 2) All Precedent Transactions with Disclosed Terms, Newest First 14 transactions with disclosed terms in this tier (40 recorded) · multiples on LTM financials at announcement where disclosed · deal values link to the underlying filing · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. 57 precedent record(s) carry data-quality flags (deal value unit unresolved; divestiture roles reassigned; duplicate precedent id); figures are shown as recorded in the filing. 26 recorded transactions with neither a disclosed value nor a multiple are omitted from the precedent list and the case studies (kept in the companion workbook). Deal multiples are LTM at announcement (Definitive, from filings); they are not directly comparable to the CY2027E public basis and no spread is claimed. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 19 Date Transaction EV EV/LTM Rev EV/LTM EBITDA Why it matters Jul-2018 Motec GmbH → AMETEK, Inc. n/a 2.6x n/a Apr-2017 Keysight Technologies → Ixia, Inc. n/a 13.7x 15.9x May-2014 Cobham plc → Aeroflex Holding Corp. n/a n/a 11.1x Apr-2014 AMETEK, Inc. → Zygo Corp. n/a n/a 12.3x n/a n/a → Bruker Corporation n/a 2.6x 15.3x Value shown as recorded in the filing; status defaulted announced.

  20. 20
    06 · METHODOLOGY

    Sources, Assumptions and Data Quality

    Methodology slide explaining the sources, valuation basis and data-quality treatment behind the report.

    Every figure in this report links back to the record it came from, whether a filing, a consensus estimate or a market price. Where a figure has no direct link, this section names the source and the basis on which it was read, so any number here can be traced independently. This is the reference page for a reader who wants to verify a specific figure rather than take it on faith.

    Everything on this page

    06 · METHODOLOGY Sources, Assumptions and Data Quality How this report was built, what was excluded, and where every underlying disclosure lives · as of 2026-09-28 Every figure in this report links to the record it was taken from. Where a figure has no link, the appendix names its source and the basis on which it was read. Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice 20 VALUATION BASIS Primary valuation basis: EV / EBITDA on CY2027E consensus (6 of 8 companies eligible; multiples failing the platform's plausibility gates are excluded, never plotted). EV / EBITDA on CY2027E is the lead convention: it is the sector-appropriate prior for Test, Measurement and Inspection Equipment and it clears the coverage gate with 6 of 8 companies (75%). EV / Revenue, P / E are carried as a cross-check. The set earns: 6 of the 7 companies with a reported forward EBITDA carry a meaningful one, so the profit multiple leads and a revenue multiple would understate what the market is pricing. DATA QUALITY & EXCLUSIONS 4 records were excluded or quarantined by the platform's validation gates (unit errors, implausible ratios, ineligible securities and classification failures); the full ledger ships in the companion tables and never feeds a statistic in this report. DEFINITIVE VS DIRECTIONAL Definitive content is disclosed or consensus data passed through stated arithmetic. Directional content — tier boundaries, situation cuts, "why it matters" commentary, the agenda pages — is NeuraCap analyst judgment and is labeled as such where it appears. WHAT THIS REPORT IS NOT This report characterises a sector. It does not recommend buying, selling or holding any security, and no statement in it should be read as investment advice or a price target. WHERE THE DATA LIVES 408 registered source documents stand behind the figures in this report. Metric hyperlinks throughout the deck open the specific filing or data record; by publisher: sec.gov (407) · home.treasury.gov (1). The companion workbook beside this deck carries the complete source index.

  21. 21

    Higher Ratings Sit Alongside Margin, Specialisation and Durable Earnings.

    Closing slide restating that higher ratings sit alongside margin, specialisation and durable earnings.

    Higher ratings in this sector sit alongside margin, specialisation and durable earnings, not alongside growth alone. The companion tables carry the full universe and source index for any figure a reader wants to trace further.

    Everything on this page

    Higher Ratings Sit Alongside Margin, Specialisation and Durable Earnings. NeuraCap AI — Test, Measurement and Inspection Equipment Coverage September 2026 · Prepared by NeuraCap AI · Confidential Test, Measurement and Inspection Equipment Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 21

Sources and methodology

This report covers Test, Measurement and Inspection Equipment (Industrials › Capital Goods › Test, Measurement and Inspection Equipment) with market data and consensus estimates as of September 28, 2026. The company universe is the 8 listed companies whose core business is Test, Measurement and Inspection Equipment according to NeuraCap's industry classification of each company's reported business segments (a company is included only when this industry is central to what it does, not merely adjacent to it). Companies in the set: AMETEK, Inc. (AME), Keysight Technologies, Inc. (KEYS), Mistras Group, Inc. (MG), MIND Technology, Inc. (MIND), Mettler-Toledo International Inc. (MTD), OSI Systems, Inc. (OSIS), Ralliant Corp (RAL), Viavi Solutions Inc. (VIAV). The market map groups them by business vertical — General-purpose bench and handheld test instruments: 4 companies (KEYS, RAL, OSIS, MIND); Adjacent models: 4 companies (AME, MTD, VIAV, MG). 6 of the 8 companies carry a valid multiple on the primary valuation basis and form the rated set behind every cohort statistic; the others are shown but do not enter the statistics.

Scope and company universe

This report covers Test, Measurement and Inspection Equipment (Industrials › Capital Goods › Test, Measurement and Inspection Equipment) with market data and consensus estimates as of September 28, 2026. The company universe is the 8 listed companies whose core business is Test, Measurement and Inspection Equipment according to NeuraCap's industry classification of each company's reported business segments (a company is included only when this industry is central to what it does, not merely adjacent to it). Companies in the set: AMETEK, Inc. (AME), Keysight Technologies, Inc. (KEYS), Mistras Group, Inc. (MG), MIND Technology, Inc. (MIND), Mettler-Toledo International Inc. (MTD), OSI Systems, Inc. (OSIS), Ralliant Corp (RAL), Viavi Solutions Inc. (VIAV). The market map groups them by business vertical — General-purpose bench and handheld test instruments: 4 companies (KEYS, RAL, OSIS, MIND); Adjacent models: 4 companies (AME, MTD, VIAV, MG). 6 of the 8 companies carry a valid multiple on the primary valuation basis and form the rated set behind every cohort statistic; the others are shown but do not enter the statistics.

What was excluded and why

4 records failed a validation gate and never feed a statistic in this report (4 excluded from aggregate). Each exclusion, with its reason: MIND — EBITDA is non-positive; EV/EBITDA is n/m (effect: excluded from aggregate) · MIND — EBITDA is non-positive; EV/EBITDA is n/m (effect: excluded from aggregate) · RAL — Non-positive EPS; P/E is n/m (effect: excluded from aggregate) · VIAV — Non-positive EPS; P/E is n/m (effect: excluded from aggregate)

Primary valuation basis and how it was chosen

Primary valuation basis: EV / EBITDA on CY2027E consensus (6 of 8 companies eligible; multiples failing the platform's plausibility gates are excluded, never plotted). EV / EBITDA on CY2027E is the lead convention: it is the sector-appropriate prior for Test, Measurement and Inspection Equipment and it clears the coverage gate with 6 of 8 companies (75%). EV / Revenue, P / E are carried as a cross-check. The set earns: 6 of the 7 companies with a reported forward EBITDA carry a meaningful one, so the profit multiple leads and a revenue multiple would understate what the market is pricing. The basis is selected in two steps: the industry's customary valuation conventions set the order of preference, and each convention is then tested for coverage — the share of companies with a valid, plausibility-checked multiple on the chosen period. A convention is used only when enough companies carry it; the best-covered convention is used, and disclosed, when none clears the threshold. Coverage measured for this report — EV / EBITDA: 6 of 8 companies; EV / rEVenue: 8 of 8 companies; P/E: 8 of 8 companies. 1 company shows a non-meaningful EV / EBITDA denominator and is excluded from that statistic.

How the multiples and statistics are computed

Enterprise value (EV) is market capitalisation at the as-of date plus total debt minus cash and equivalents from the latest reported balance sheet, reconciled against the platform's stored value and disclosed where the two differ. Forward multiples divide EV (or the share price for P/E) by the consensus estimate for the stated calendar period; trailing multiples use the last twelve months of reported figures from SEC filings. A multiple with a negative or immaterial denominator is treated as not meaningful and excluded from every statistic. Cohort statistics are medians and quartiles over the rated set only; a group median with fewer than three observations is shown as the single company's figure and labelled as such. Valuation tiers cut the rated set at its quartiles (tiers cut at the rated set's quartiles: Premium ≥20.2x, Core 12.9x–20.2x, Discount <12.9x — NeuraCap groupings). Revenue growth compares consecutive calendar-year consensus revenue; EBITDA margin divides consensus EBITDA by consensus revenue for the same period. Figures shown in this report and the calculation behind each: 17.2x = median(ev_ebitda CY2027E) (6 rated companies) · 22.2x = median(ev_ebitda CY2027E) within Premium tier (n=2) · 17.2x = median(ev_ebitda CY2027E) within Core tier (n=2) · 10.1x = median(ev_ebitda CY2027E) within Discount tier (n=2) · 16.3x = median(ev_ebitda CY2027E) | growth ≥ 7% (n=3) · 20.9x = median(ev_ebitda CY2027E) | growth < 7% (n=3) · 20.9x = median(ev_ebitda CY2027E) | EBITDA margin ≥ 24% (n=3) · 11.8x = median(ev_ebitda CY2027E) | EBITDA margin < 24% (n=3) · 32% = median Rule of 40 score (revenue growth + EBITDA margin) (n=6)

Precedent transactions: what is in the record and why

The precedent record holds the M&A transactions in Test, Measurement and Inspection Equipment recorded from SEC filings (8-K announcements and the documents they reference), newest first, with each value and multiple linked to the exact passage in the filing that states it. 40 transactions were recorded for this industry; 14 are shown. 26 recorded transactions with neither a disclosed value nor a multiple are omitted because they say nothing about price; they remain in the companion workbook. Deal multiples are enterprise value over the target's last-twelve-month revenue or EBITDA at announcement, as disclosed; they are not restated to the public basis and no spread to the public multiples is claimed. Before a transaction reaches the record it passes a screen for mirrored or duplicate filings of the same deal, for divestitures where the filer is the seller rather than the buyer, for carve-outs recorded under the parent's name, and for values whose citation describes something other than the price paid (a debt raise, a termination fee); such records are corrected or excluded and the correction is noted. Data-quality notes on this record: 20 × deal value unit unresolved; 29 × no evidence record; 5 × duplicate precedent id; 3 × divestiture roles reassigned. Case studies lead with the 3 richest stories — disclosed value, a readable multiple, newest first.

Sources

Company financials and transaction terms come from the companies' own SEC filings on EDGAR (10-K, 10-Q and 8-K documents), linked from each figure in the report. Forward figures are analyst consensus estimates for the calendar periods shown. Share prices and market capitalisations are market data as of September 28, 2026. Treasury yields are published by the U.S. Department of the Treasury. 412 source documents stand behind this report; by publisher domain: sec.gov, home.treasury.gov (1). Every figure on every page is traceable to one of these records; nothing in the report is derived from outside data.

Interpretation and important notice

Tier labels, situation maps, the agenda and the implications pages are NeuraCap analytical views drawn from the recorded evidence and are labelled as such. The report is informational: it is not investment advice, not a recommendation to buy or sell any security, not an opinion of value and not an offer of any kind. Readers should perform their own diligence before acting on anything described here.

Sources linked in the report

This report is published for information only. It is not a recommendation to buy or sell any security, an offer or solicitation, an appraisal or a fairness opinion, and no fiduciary relationship is created by reading it. Multiples that fail NeuraCap’s plausibility gates are excluded and never plotted. See the full methodology and the disclaimer.

Want this analysis for a company in Test, Measurement and Inspection Equipment?

Company valuation reports run the same method against a single business — public or private.